This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 May 31;378(22):2148.

doi: 10.1056/NEJMc1805092.

Friction in the Path to Use of Biosimilar Drugs

Brian Chen¹, Y Tony Yang², Charles Bennett

Affiliations

PMID: 29847904
DOI: 10.1056/NEJMc1805092

Comment

Friction in the Path to Use of Biosimilar Drugs

Brian Chen et al. N Engl J Med. 2018.

. 2018 May 31;378(22):2148.

doi: 10.1056/NEJMc1805092.

Authors

Brian Chen¹, Y Tony Yang², Charles Bennett

Affiliations

¹ University of South Carolina, Columbia, SC bchen@mailbox.sc.edu
² George Mason University, Fairfax, VA

PMID: 29847904
DOI: 10.1056/NEJMc1805092

No abstract available

PubMed Disclaimer

Comment in

Friction in the Path to Use of Biosimilar Drugs.
Frank RG. Frank RG. N Engl J Med. 2018 May 31;378(22):2148. doi: 10.1056/NEJMc1805092. N Engl J Med. 2018. PMID: 29847768 No abstract available.

Comment on

Friction in the Path to Use of Biosimilar Drugs.
Frank RG. Frank RG. N Engl J Med. 2018 Mar 1;378(9):791-793. doi: 10.1056/NEJMp1714908. N Engl J Med. 2018. PMID: 29490182 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations